Skip to main content
Year archive

Anuh Pharma Ltd. — 2022 filings

All 66 regulatory filings released by Anuh Pharma Ltd. (ANUHPHR) in 2022, sourced directly from the official regulator.

66 Filings
2022 Period
2022 filings (66)
Filing Released Lang
Closure of Trading Window
Regulatory Filings
2022-12-31 English
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated ....
Regulatory Filings
2022-11-15 English
Dear Sir/Madam, Pursuant to the provisions of Regulation 30 read with Schedule III Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) ....
Regulatory Filings
2022-11-08 English
Ref: Scrip Code No. 506260 Sub: Newspaper Publication of Unaudited Financial Results for the quarter ended 30.09.2022 Please find enclosed herewith the copy of newspaper ....
Regulatory Filings
2022-11-08 English
Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are enclosing ....
Regulatory Filings
2022-11-07 English
Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as ....
Regulatory Filings
2022-11-07 English
Disclosure regarding submission of application for Reclassification of Promoters under Regulation 31A(8)(c)
Regulatory Filings
2022-11-05 English
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2022 ,inter alia, to consider and approve Pursuant to the provisions of ....
Regulatory Filings
2022-10-29 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Mr. Bharat Gangani, has tendered his resignation on ....
Regulatory Filings
2022-10-20 English
Pursuant to the provisions of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants), Regulations, 2018, please find attached herewith the copy of ....
Regulatory Filings
2022-10-12 English
Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and in compliance with the Company''s Code of Conduct for prevention of Insider ....
Regulatory Filings
2022-09-30 English
We are enclosing herewith our Company's Investor Presentation for Q1 FY2023.
Regulatory Filings
2022-08-09 English
Please find enclosed herewith the copy of newspaper advertisement with respect to the Unaudited Financial Results for the quarter ended June 30, 2022, published in the Financial Express ....
Regulatory Filings
2022-08-08 English
Pursuant to the provisions of the Companies Act, 2013 and Regulation 44 of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we are enclosing herewith ....
Regulatory Filings
2022-08-06 English
We wish to inform you that 62nd Annual General Meeting of the Company has been duly convened and held on Friday, 5th August, 2022 at 4.30 PM through Video Conferencing / Other Audio Visual ....
Regulatory Filings
2022-08-06 English
We would like to inform that the Members of the Company in their meeting held on Friday, August 05, 2022, have considered and approved the request received from few Promoters/ Promoter ....
Regulatory Filings
2022-08-06 English
Pursuant to the provisions of Regulation 30 read with Schedule III and other applicable Regulations, if any, of the Securities and Exchange Board of India (Listing Obligations and Disclosure ....
Regulatory Filings
2022-08-06 English
Proceedings of the 62nd Annual General Meeting of the Shareholders of the Company.
Regulatory Filings
2022-08-06 English
Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following:
Regulatory Filings
2022-08-05 English
Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this ....
Regulatory Filings
2022-08-05 English
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2022 ,inter alia, to consider and approve Pursuant to the provisions of ....
Regulatory Filings
2022-07-27 English
Please find enclosed herewith the copy of newspaper advertisement with respect to the Notice of 62nd Annual General Meeting of the Company through Video Conferencing (VC) / Other Audio ....
Regulatory Filings
2022-07-25 English
Pursuant to the provisions of Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("LODR Regulations"), we are submitting herewith the Notice ....
Regulatory Filings
2022-07-14 English
Pursuant to the provisions of Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith ....
Regulatory Filings
2022-07-14 English
Please find enclosed herewith the copy of newspaper advertisement with respect to the Notice of 62nd Annual General Meeting of the Company through Video Conferencing (VC) / Other Audio ....
Regulatory Filings
2022-07-12 English
Pursuant to the provisions of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants), Regulations, 2018, please find attached herewith the copy of ....
Regulatory Filings
2022-07-07 English
Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and in compliance with the Company's Code of Conduct for prevention of Insider ....
Regulatory Filings
2022-06-29 English
Pursuant to the provisions of Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Register of Members & Share Transfer ....
Regulatory Filings
2022-06-15 English
Please find enclosed herewith the copies of newspaper advertisement published on June 08, 2022 in the newspapers i.e. Financial Express and Mumbai Lakshadeep. This Notice was published ....
Regulatory Filings
2022-06-08 English
Please find attached herewith the Transcript of Earnings Audio Conference Call held on Monday, 30th May, 2022 at 4.30 PM wherein Financial Performance for Quarter and year ended 31st March, ....
Regulatory Filings
2022-05-31 English
Pursuant to Regulations 30 and 46(2)(ao) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to the subject cited, please note ....
Regulatory Filings
2022-05-30 English
Please find attached herewith the Outcome of Earnings Audio Conference Call held on Monday, 30th May, 2022 at 4.30 PM wherein Financial Performance for Quarter and year ended 31st March, ....
Regulatory Filings
2022-05-30 English
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated ....
Regulatory Filings
2022-05-27 English
Pursuant to the Regulation-30of SEBI (LODR) Regulations, 2015, please find enclosed the details of investor calls held on Monday, 30th May, 2022.
Regulatory Filings
2022-05-26 English
We are submitting herewith our Company''s Investor Presentation for the month of May, 2022.
Regulatory Filings
2022-05-18 English
Pursuant to the provisions of Regulation 24A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith ....
Regulatory Filings
2022-05-17 English
With reference to our previous submission dated 14th May, 2022, please find enclosed herewith our revised submission of Audited Financial Results along with Auditor's Report for the year ....
Regulatory Filings
2022-05-16 English
Please find enclosed herewith the copy of newspaper advertisement with respect to the Audited Financial Results for the quarter and year ended 31" March, 2022, published in the Financial ....
Regulatory Filings
2022-05-16 English
We would like to inform that the Board of Directors of the Company in their meeting held on May 14, 2022, have considered and approved the request received from few Promoters/ Promoter ....
Regulatory Filings
2022-05-14 English
Anuh Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2022, inter alia, has recommended final dividend of Rs. 1.75/- per equity shares ....
Regulatory Filings
2022-05-14 English
Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following:
Regulatory Filings
2022-05-14 English
Anuh Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2022, inter alia has recommended final dividend of Rs. 1.75/- per equity share ....
Regulatory Filings
2022-05-14 English
Outcome of Board Meeting held on 14th May 2022.
Regulatory Filings
2022-05-14 English
Please find attached the request letters dated May 12, 2022, received from certain Promoters/ Promoter Group of the Company seeking reclassification of their shareholding from ''Promoters/ ....
Regulatory Filings
2022-05-13 English
Anuh Pharma Ltd. has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 14, 2022, inter alia, to consider and approve the audited financial ....
Regulatory Filings
2022-05-07 English
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2022 ,inter alia, to consider and approve Pursuant to the provisions of ....
Regulatory Filings
2022-05-07 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2022-04-29 English
Pursuant the provisions of Regulation 40(10) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith ....
Regulatory Filings
2022-04-11 English
Compliance Certificate for the period ended 31/03/2022.
Regulatory Filings
2022-04-08 English
Pursuant to the provisions of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants), Regulations, 2018, please find attached herewith the copy of ....
Regulatory Filings
2022-04-06 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that based on the recommendation of Audit Committee, the ....
Regulatory Filings
2022-03-28 English
Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and in compliance with the Company's Code of Conduct for prevention of Insider ....
Regulatory Filings
2022-03-28 English
Withdrawal of application for Direct Listing of 5,01,12,000 Equity Shares of Rs. 5.00/- each fully paid up of Anuh Pharma Limited ('the Company) on the National Stock Exchange of India ('NSE').
Regulatory Filings
2022-03-10 English
We are submitting herewith the Transcript of Earnings Audio Conference Call held on 7th February, 2022 at 4.00 PM wherein Financial Performance for Quarter and nine months ended 31st December, ....
Regulatory Filings
2022-02-09 English
We are submitting herewith the Outcome of Earnings Audio Conference Call held on February 07, 2022 at 4.00 PM wherein Financial Performance for Quarter and nine months ended December 31, ....
Regulatory Filings
2022-02-07 English
We are submitting herewith our Company''s revised Investor Presentation for the month of February, 2022.
Regulatory Filings
2022-02-07 English
We are submitting herewith our Company''s Investor Presentation for the month of February, 2022.
Regulatory Filings
2022-02-07 English
Please find enclosed herewith the copy of newspaper advertisement with respect to the Unaudited Financial Results for the quarter and nine months ended December 31, 2021, published in the ....
Regulatory Filings
2022-02-05 English
Please find attached herewith the details for Earnings Call Invite to join the Conference Call to be held on Monday, 7th February, 2022 at 4.00 PM to discuss the Financial Performance for ....
Regulatory Filings
2022-02-04 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that based on the recommendation of Nomination and Remuneration ....
Regulatory Filings
2022-02-04 English
Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following:
Regulatory Filings
2022-02-04 English
Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as ....
Regulatory Filings
2022-02-04 English
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2022 ,inter alia, to consider and approve Pursuant to the provisions of ....
Regulatory Filings
2022-01-25 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company (the "Board") ....
Regulatory Filings
2022-01-21 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Ms. Ashwini Ambrale, has tendered her resignation on ....
Regulatory Filings
2022-01-13 English
Pursuant to the provisions of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants), Regulations, 2018, please find attached herewith the copy of ....
Regulatory Filings
2022-01-06 English